Figure 1From: HER-2, p53, p21 and hormonal receptors proteins expression as predictive factors of response and prognosis in locally advanced breast cancer treated with neoadjuvant docetaxel plus epirubicin combinationKaplan-Meyer curve for DFS in sixty patients subjected to Neoadjuvant chemotherapy with docetaxel and epirubicin according to HER-2 protein expression.Back to article page